[Does diagnostic ureterorenoscopy increase the risk of bladder recurrence after total nephroureterectomy? A review of the literature].

L’urétérorénoscopie diagnostique augmente-t-elle le risque de récidive vésicale après néphro-urétérectomie totale ? Une revue de la littérature.
Bladder recurrence Endoscopie Endoscopy Nephroureterectomy Néphro-urétérectomie totale Oncological outcomes Récidive vésicale Résultats oncologiques Ureteroscopy Urothelial tumor Urétéroscopie

Journal

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie
ISSN: 1166-7087
Titre abrégé: Prog Urol
Pays: France
ID NLM: 9307844

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 01 05 2018
revised: 04 11 2018
accepted: 01 02 2019
pubmed: 9 3 2019
medline: 31 7 2019
entrez: 9 3 2019
Statut: ppublish

Résumé

The objective of our study was to evaluate, in a review of the literature, the impact of diagnostic ureteroscopy before total nephroureterectomy (NUT) on the risk of bladder recurrence. We conducted a literature review in the Pubmed database in March 2018. Initial research identified 45 publications. Following full text screening, 9 studies were finally included, with a total of 1041 NUT with URS prior versus 2909 NUT alone. The primary endpoint was bladder recurrence. Secondary objectives were specific survival and overall survival. Bladder recurrence was reported in the 9 studies included. Diagnostic ureteroscopy was significantly associated with an increased risk of post-NUT bladder recurrence (HZ 1.42 [1.29-1.56], P<0.01). The specific survival and overall survival at 5 years, were reported in respectively 4 and 2 studies. There was no impact of the pre-NUT diagnostic URS on the specific survival (HZ 0.75 [0.54-1.03], P=0.08) or post-NUT overall survival (HZ 1.15 [0.68-1.96], P=0.59). The URS diagnostic before NUT for TVEUS is associated with a significant increase in the risk of postoperative bladder recurrence.

Identifiants

pubmed: 30846356
pii: S1166-7087(19)30036-3
doi: 10.1016/j.purol.2019.02.005
pii:
doi:

Types de publication

Journal Article Review

Langues

fre

Pagination

138-146

Informations de copyright

Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Auteurs

M Baboudjian (M)

Service d'urologie, CHU Conception, AP-HM, 147, boulevard Baille, 13005 Marseille, France. Electronic address: Michael.BABOUDJIAN@ap-hm.fr.

E Lechevallier (E)

Service d'urologie, CHU Conception, AP-HM, 147, boulevard Baille, 13005 Marseille, France.

F Michel (F)

Service d'urologie, CHU Conception, AP-HM, 147, boulevard Baille, 13005 Marseille, France.

K Ben Othman (K)

Service d'urologie, CHU Conception, AP-HM, 147, boulevard Baille, 13005 Marseille, France.

T Martin (T)

Service d'urologie, CHU Conception, AP-HM, 147, boulevard Baille, 13005 Marseille, France.

E Di Crocco (E)

Service d'urologie, CHU Conception, AP-HM, 147, boulevard Baille, 13005 Marseille, France.

A Akiki (A)

Service d'urologie, CHU Conception, AP-HM, 147, boulevard Baille, 13005 Marseille, France.

S Gaillet (S)

Service d'urologie, CHU Conception, AP-HM, 147, boulevard Baille, 13005 Marseille, France.

V Delaporte (V)

Service d'urologie, CHU Conception, AP-HM, 147, boulevard Baille, 13005 Marseille, France.

G Karsenty (G)

Service d'urologie, CHU Conception, AP-HM, 147, boulevard Baille, 13005 Marseille, France.

R Boissier (R)

Service d'urologie, CHU Conception, AP-HM, 147, boulevard Baille, 13005 Marseille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH